BlackRock Investment Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

BlackRock Investment Management’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-136,871	Closed	-$4.71M	–	4193
2014 Q4	$4.71M	Sell	136,871 -1,085	-0.8%	-$35.4K	0.01%	1401
2014 Q3	$4.12M	Buy	137,956 +181	+0.1%	+$3.84K	0.01%	1476
2014 Q2	$2.76M	Buy	137,775 +1,683	+1%	+$38.6K	﹤0.01%	1825
2014 Q1	$3.7M	Buy	136,092 +332	+0.2%	+$8.81K	0.01%	1598
2013 Q4	$2.81M	Sell	135,760 -3,148	-2%	-$59.3K	﹤0.01%	1772
2013 Q3	$2.53M	Buy	138,908 +8,509	+7%	+$154K	﹤0.01%	1780
2013 Q2	$2.17M	Buy	+130,399	New	+$2.08M	﹤0.01%	1796

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Investment Management's AUXL Position: Q1 2015 in Review

BlackRock Investment Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 136,871 shares — an estimated $4.71M sold.

BlackRock Investment Management first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $4.71M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

BlackRock Investment Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
BlackRock Investment Management sold 136,871 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $4.71M.
BlackRock Investment Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
BlackRock Investment Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $4.71M in Q4 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on BlackRock Investment Management's 13F filing for Q1 2015, filed 13 May 2015.